CIK 0001858685
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Biofrontera Inc.
Sign in to watch- Ticker
- BFRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473765675
- Phone
- +1 781-245-1325
- Business address
- 120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-18 | Monaco Erica L. Chief Executive Officer | Option exercise | +76,336 | 133,025 | ||
| 2023-05-18 | Monaco Erica L. Chief Executive Officer | Option exercise · Restricted Stock Units | −76,336 | 76,336 | ||
| 2022-07-01 | Monaco Erica L. Chief Executive Officer | Option exercise | +56,689 | 56,689 | ||
| 2022-07-01 | Monaco Erica L. Chief Executive Officer | Option exercise · Restricted Stock Units | −56,689 | 152,672 | ||
| 2022-05-18 | Monaco Erica L. Chief Executive Officer | Grant or award · Restricted Stock Units | +152,672 | 209,361 | ||
| 2022-05-18 | Monaco Erica L. Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +152,672 | 209,361 | ||
| 2021-12-09 | Monaco Erica L. Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +56,689 | 56,689 | ||
| 2021-12-09 | Monaco Erica L. Chief Executive Officer | Grant or award · Restricted Stock Units | +56,689 | 56,689 | ||
| 2021-12-09 | Monaco Erica L. Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +56,689 | 56,689 |
Page 1 of 1 · 9 trades